Expression of insulin-like growth factor-I in rat glioma cells is associated with change in both immunogenicity and apoptosis

Neuroscience Letters

Volumn 281, Issue 1, 2000, Pages 13-16

  Ly, Adama ^a   Bouchaud, Claude ^b   Henin, Dominique ^a   Sanson, Marc ^b   Delattre, Jean Yves ^b   Pan, Yuexin ^c   Anthony, Donald ^c   Duc, Huynh T ^b   Evrard, Philippe ^a   Trojan, Jerzy ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antisense; Apoptosis; B7; Glioma; Insulin like growth factor I; MHC I

Indexed keywords

B7 ANTIGEN; COMPLEMENTARY DNA; COMPLEMENTARY RNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SOMATOMEDIN C;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLIOMA; GLIOMA CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, CD80; APOPTOSIS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IN SITU NICK-END LABELING; INSULIN-LIKE GROWTH FACTOR I; RATS; RNA, ANTISENSE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033964264     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00758-8     Document Type: Article

References (24)

1. Anthony D., Pan Y., Wu S., Shen F., Guo Y. Ex vivo and in vivo IGF-I antisense RNA strategies for treatment of cancers in humans. Adv. Exp. Med. Biol. 451:1998;27-34.
2. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:1995;249-252.
3. Chen L., Ashe S., Brady W.A., Hellstrom I., Hellstrom K.E., Ledbetter I.A., McGrowan P., Linsley P.S. Co-stimulation of anti-tumor immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1992;1093-1102.
4. Culver K.W., Rarn Z., Wallbridge S., Ishii H., Oldfield E.H., Blaese R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1992;1550-1552.
5. D'Ambrosio C., Ferber A., Resnicoff M., Baserga R. A soluble insulin-like growth factor-receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res. 56:1996;4013-4020.
6. Ellouk-Achard S., Djenabi S., De Oliveira G.A., Desauty G., Duc H.T., Zohair M., Trojan J., Claude J.R., Sarasin A., Lafarge-Frayssinet C. Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA. J. Hepatol. 29:1998;807-818.
7. Froesch C.S., Schwander J., Zapf J. Actions of insulin-like growth factors. Annu. Rev. Physiol. 47:1985;443-467.
8. Harding F., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. CD28- mediated and signalling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature. 356:1992;607-609.
9. Lafarge- Frayssinet, C., Duc, H.T., Sarasin, A., Frayssinet, C., Anthony, D., Guo, Y. and Trojan J., Antisense IGF-I transfer into a rat hepatoma cell linee inhibits tumorigenesis by modulating MHC-I Cancer Gene Ther., 4(5) (1997) 276-285.
10. Resnicoff M., Sell C., Rubini M., Coppola D., Ambrose D., Baserga R. Rat glioblastoma cells expressing an anti-sense RNA to the insulin-like growth factor I (IGF-I) receptor are non-tumorigenic and induce regression of wild-type tumors. Cancer Res. 54:1994;2218-2222.
11. Resnicoff M., Abraham D., Yutanawiboonchai W., Rotman H.L., Kajustora J., Rubin R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vitro. Cancer Res. 55:1995;2463-2469.
12. Ridoux V., Robert J.J., Zhang X., Perricaudet M., Mallet J., Le-Gal-La-Salle G. Adenoviral vectors as functional retrograde neuronal tracers. Brain Res. 648:1994;171-175.
13. Rodriguez-Tarduchy G., Collins M.K.L., Garcia I., Lopez-Rivas A. Insulin-like Growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. Eur. J. Immunol. 149:1992;535-540.
14. Saji M., Moriarty J., Ban T., Singer D., Kohn L. Major Histocompatibility Complex class I gene expression in rat thyroid cells is regulated by hormones, methimazole and iodide as well as interferon. J. Clin. Endocrinol. Metab. 75:(3):1992;871-878.
15. Sandberg A.C., Engberg C., Lake M., von Holst H., Sara V.R. The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci Lett. 93:(1):1988;114-119.
16. Schwartz R.H. Co-stimulation of T Iymphocytes: the role of CD28 CTLA-4 and B7/BBI in interleukin-2 production and immunotherapy. Cell. 71:1992;1065-1068.
17. Taghian, A., Bucach, W., Zietman, A., Freeman, J., Gioioso, D. and Smit, H.D., Quantitative comparison between the transplantability of human and murine tumors into the brain of NCr/Scd- nu/nu Nude and severe combined immunodeficient mice. Cancer Res., 53 (l993) 5018-5021.
18. Townsend S.E., Allison J.A. Tumor rejection after direct co-stimulation of CD8+ T cell transfected melanoma cells. Science. 259:1993;368-370.
19. Trojan J., Blossey B.K., Johnson T.R., Rudin S.D., Tykocinsky M., Ilan J., Ilan J. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor 1. Proc. Natl. Acad. Sci. USA. 89:1992;4874-4878.
20. Trojan J., Johnson T.R., Rudin S.D., Ilan J., Tykocinsky M., Ilan J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science. 259:1993;94-97.
21. Trojan J., Johnson T., Rudin S., Kelley K., Shevelev A., Abdul-Kzarim F., Anthony D., Tykocinski M., Ilan J. Gene therapy of murine teratocarcinoma: separate functions for insulin like growth factor I and II in immunogenicity and differentiation. Proc. Natl. Acad. Sci. USA. 91:1994;6088-6092.
22. Trojan J., Duc H., Upegui-Gonzalez L., Hor F., Guo Y., Anthony D., Ilan J. Presence of MHC-I and B-7 molecules in rat and human glioma cells expressing antisense lGF-1 mRNA. Neurosci Lett. 212:1996;9-12.
23. Upegui-Gonzalez, L.C., Duc, H.T., Buisson, Y., Arborio, M., Lafarge-Frayssinet, C., Jasmin, C., Guo, Y. and Trojan, J., Use of the IGF-I antisense strategy in the treatment of the hepatocarcinoma, Adv. Exp. Med. Biol., 451 (1997/8) 35-42.
24. Weintraub H., Izant J.G., Harland R.M. Anti-sense RNA as a molecular tool for genetic analysis. Trends Gen. 1:(1):1985;23-25.